The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 10%.
FRP Holdings Inc
FRPH · USD · Market cap $424M · 25 employees
FRP Holdings, Inc.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-01
Screened 2026-09-01 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
FRP Holdings Inc holds its Accumulation at $22.07. Consolidating, no directional conviction, held for 15 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 15 days |
| Price at the screen | $22.07 |
| Valuation | 2,207.00 trailing · 52.55 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.52 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 26.19% | Below 33% | Interest-bearing debt is just 26.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 13.04% | Below 49% | Money owed to the company is 13.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-01 screen. The gold marker is the market price at the same screen. The price runs 50.0% above the base estimate.
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-01 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 52.5xexpensive even after accounting for its growth |
| Trailing P/E | 2,207.0xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.01 |
| EPS, forward | 0.42 |
| Revenue growth | +2.3%slow but positive growth |
| Profit margin | 0.3%barely profitable |
| Return on equity | -0.1%not currently earning a positive return on equity |
| FCF yield | 2.41% |
| Debt to equity | 0.47minimal debt: a conservative balance sheet |
| Current ratio | 5.86comfortably covers its short-term bills |
| Beta | 0.52steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 20.53 - 25.81 |
| Moat | NONE |
| Market cap | $424M |
| Employees | 25 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 10%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 10%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $22.17 | +8.8% | · | $1,088 | +8.8% |
| 2 months | $22.53 | +7.0% | · | $1,070 | +7.0% |
| 3 months | $22.52 | +7.1% | · | $1,071 | +7.1% |
| 6 months | $23.47 | +2.7% | · | $1,027 | +2.7% |
| 1 year | $27.62 | -12.7% | · | $873 | -12.7% |
| 2 years | $29.92 | -19.4% | · | $806 | -19.4% |
| 3 years | $29.98 | -19.6% | · | $804 | -19.6% |
| 5 years | $29.17 | -17.4% | · | $826 | -17.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FRPH does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.